You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 42 No. 4, April 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clonidine in Outpatient Detoxification From Methadone Maintenance

Herbert D. Kleber, MD; Charles E. Riordan, MD; Bruce Rounsaville, MD; Thomas Kosten, MD; Dennis Charney, MD; Joseph Gaspari, MD; Izola Hogan, RN; Carol O'Connor

Arch Gen Psychiatry. 1985;42(4):391-394.


Abstract

• Inpatient narcotic detoxification with clonidine hydrochloride has been used since 1978. Outpatient withdrawal, potentially more useful, has not been adequately studied. This report describes a double-blind random assignment of 49 methadone hydrochloride—maintained patients whose dose had been lowered to 20 mg. Twenty-five were detoxified using methadone at 1-mg decrements, 24 by abrupt substitution with clonidine. Approximately 40% of both groups achieved successful detoxification, with one third maintaining abstinence over the subsequent six months. The groups were also largely equivalent on withdrawal symptoms, but the clonidine group experienced symptoms in the first half of the study and the methadone group in the second half. Clonidine appears to be a safe and efficacious outpatient treatment for opiate withdrawal, although the results were less favorable than those obtained in open or inpatient studies.



Author Affiliations

From the Department of Psychiatry, Yale University School of Medicine, and the Connecticut Mental Health Center, New Haven.


Footnotes

Accepted for publication Jan 27, 1984.

Reprint requests to Connecticut Mental Health Center, 34 Park St, New Haven, CT 06508 (Dr Kleber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of Pharmacological Treatments for Opioid-Dependent Adolescents: A Randomized Controlled Trial
Marsch et al.
Arch Gen Psychiatry 2005;62:1157-1164.
ABSTRACT | FULL TEXT  

Anesthesia-Assisted vs Buprenorphine- or Clonidine-Assisted Heroin Detoxification and Naltrexone Induction: A Randomized Trial
Collins et al.
JAMA 2005;294:903-913.
ABSTRACT | FULL TEXT  

Treating Opioid Dependence: Growing Implications for Primary Care
Krantz and Mehler
Arch Intern Med 2004;164:277-288.
ABSTRACT | FULL TEXT  

What works in drug addiction?
Luty
Adv. Psychiatr. Treat. 2003;9:280-288.
ABSTRACT | FULL TEXT  

Management of Drug and Alcohol Withdrawal
Kosten and O'Connor
NEJM 2003;348:1786-1795.
FULL TEXT  

Pharmacologic Treatment of Heroin-Dependent Patients
O'Connor and Fiellin
ANN INTERN MED 2000;133:40-54.
ABSTRACT | FULL TEXT  

Randomized, Controlled Trial of Clonidine for Smoking Cessation in a Primary Care Setting
Franks et al.
JAMA 1989;262:3011-3013.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.